$REGN
REGENERON PHARMACEUTICALS, INC.

2019 Q3 Form 10-Q Financial Statement

#000153217619000034 Filed on November 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3 2018 Q2
Revenue $1.744B $1.664B $1.608B
YoY Change 4.82% 10.85% 9.38%
Cost Of Revenue $225.5M $110.4M $91.70M
YoY Change 104.26% 137.99% 117.64%
Gross Profit $1.518B $1.553B $1.516B
YoY Change -2.25% 6.79% 6.19%
Gross Profit Margin 87.07% 93.36% 94.3%
Selling, General & Admin $304.4M $369.2M $364.8M
YoY Change -17.55% 20.35% 18.86%
% of Gross Profit 20.05% 23.77% 24.06%
Research & Development $526.0M $557.0M $529.3M
YoY Change -5.57% 5.14% 3.79%
% of Gross Profit 34.65% 35.86% 34.91%
Depreciation & Amortization $52.90M $35.40M $33.60M
YoY Change 49.44% -6.35% -4.27%
% of Gross Profit 3.48% 2.28% 2.22%
Operating Expenses $830.4M $926.2M $894.1M
YoY Change -10.34% 10.72% 9.45%
Operating Profit $738.5M $626.9M $622.2M
YoY Change 17.8% 11.96% 13.06%
Interest Expense $7.800M $7.400M $6.900M
YoY Change 5.41% 19.7% 27.75%
% of Operating Profit 1.06% 1.18% 1.11%
Other Income/Expense, Net $30.00M $9.000M $33.90M
YoY Change 233.33% 58.48% -238.58%
Pretax Income $768.5M $635.9M $656.1M
YoY Change 20.85% 12.43% 24.77%
Income Tax $98.90M $41.20M $104.7M
% Of Pretax Income 12.87% 6.48% 15.96%
Net Earnings $669.6M $594.7M $551.4M
YoY Change 12.59% 53.15% 42.22%
Net Earnings / Revenue 38.4% 35.75% 34.29%
Basic Earnings Per Share $6.12 $5.50 $5.12
Diluted Earnings Per Share $5.86 $5.17 $4.82
COMMON SHARES
Basic Shares Outstanding 109.4M shares 108.0M shares 107.8M shares
Diluted Shares Outstanding 114.2M shares 115.1M shares 114.5M shares

Balance Sheet

Concept 2019 Q3 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.878B $2.192B $1.684B
YoY Change 31.3% 58.96% 32.81%
Cash & Equivalents $1.385B $1.088B $917.9M
Short-Term Investments $1.493B $1.104B $766.0M
Other Short-Term Assets $659.0M $644.0M $460.0M
YoY Change 2.33% 80.39% 20.73%
Inventory $1.344B $1.040B $928.6M
Prepaid Expenses
Receivables $2.028B $1.666B $1.534B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.109B $5.720B $4.815B
YoY Change 24.29% 38.3% 24.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.771B $2.524B $2.462B
YoY Change 9.78% 10.99% 8.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.113B $1.874B $2.045B
YoY Change 66.12% 41.22% 92.02%
Other Assets $137.9M $125.2M $85.67M
YoY Change 10.15% 241.9% 131.77%
Total Long-Term Assets $6.830B $5.086B $5.137B
YoY Change 34.29% 11.4% 20.98%
TOTAL ASSETS
Total Short-Term Assets $7.109B $5.720B $4.815B
Total Long-Term Assets $6.830B $5.086B $5.137B
Total Assets $13.94B $10.81B $9.952B
YoY Change 29.0% 24.19% 22.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $336.0M $172.0M $172.0M
YoY Change 95.35% 11.69% 13.91%
Accrued Expenses $821.0M $782.0M $671.0M
YoY Change 4.99% 45.35% 23.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.765B $1.417B $1.331B
YoY Change 24.57% 24.47% 29.37%
LONG-TERM LIABILITIES
Long-Term Debt $713.0M $707.0M $706.0M
YoY Change 0.85% 0.71% 0.71%
Other Long-Term Liabilities $273.0M $194.0M $190.0M
YoY Change 40.7% 54.95% 63.92%
Total Long-Term Liabilities $273.0M $194.0M $190.0M
YoY Change 40.7% 54.95% 63.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.765B $1.417B $1.331B
Total Long-Term Liabilities $273.0M $194.0M $190.0M
Total Liabilities $3.435B $2.937B $2.766B
YoY Change 16.94% 10.86% 6.96%
SHAREHOLDERS EQUITY
Retained Earnings $6.588B $4.434B $3.839B
YoY Change 48.58% 59.88% 60.98%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $488.4M $396.4M $353.9M
YoY Change 23.22% 25.34% 11.89%
Treasury Stock Shares 4.167M shares 3.990M shares 3.885M shares
Shareholders Equity $10.50B $7.868B $7.186B
YoY Change
Total Liabilities & Shareholders Equity $13.94B $10.81B $9.952B
YoY Change 29.0% 24.19% 22.77%

Cashflow Statement

Concept 2019 Q3 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income $669.6M $594.7M $551.4M
YoY Change 12.59% 53.15% 42.22%
Depreciation, Depletion And Amortization $52.90M $35.40M $33.60M
YoY Change 49.44% -6.35% -4.27%
Cash From Operating Activities $557.3M $453.0M $394.6M
YoY Change 23.02% 9.18% -1389.54%
INVESTING ACTIVITIES
Capital Expenditures -$121.7M -$106.2M -$112.0M
YoY Change 14.6% 77.89% 104.38%
Acquisitions
YoY Change
Other Investing Activities -$85.30M -$180.5M -$373.0M
YoY Change -52.74% -39.69% 222.94%
Cash From Investing Activities -$207.0M -$286.7M -$485.0M
YoY Change -27.8% -20.09% 184.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.00M 3.700M -11.20M
YoY Change -397.3% -145.12% -108.39%
NET CHANGE
Cash From Operating Activities 557.3M 453.0M 394.6M
Cash From Investing Activities -207.0M -286.7M -485.0M
Cash From Financing Activities -11.00M 3.700M -11.20M
Net Change In Cash 339.3M 170.0M -101.6M
YoY Change 99.59% 254.91% 50.3%
FREE CASH FLOW
Cash From Operating Activities $557.3M $453.0M $394.6M
Capital Expenditures -$121.7M -$106.2M -$112.0M
Free Cash Flow $679.0M $559.2M $506.6M
YoY Change 21.42% 17.83% 1993.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000872589
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2019Q3 regn Finance Lease Rightof Use Asset Accumulated Amortization
FinanceLeaseRightofUseAssetAccumulatedAmortization
72500000 USD
CY2017Q1 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017Q1 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3990021 shares
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4167018 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19034
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown,
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
dei City Area Code
CityAreaCode
914
dei Local Phone Number
LocalPhoneNumber
847-7000
dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
dei Trading Symbol
TradingSymbol
REGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1384800000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1467700000 USD
CY2019Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1493100000 USD
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1342200000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2027700000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1723700000 USD
CY2019Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
345400000 USD
CY2018Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
226400000 USD
CY2019Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
286900000 USD
CY2018Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
293100000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
1344300000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
226900000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
243300000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
7109100000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6447600000 USD
CY2019Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3112600000 USD
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1755000000.0 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2771400000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2575800000 USD
CY2019Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
808300000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
828700000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137900000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
127400000 USD
CY2019Q3 us-gaap Assets
Assets
13939300000 USD
CY2018Q4 us-gaap Assets
Assets
11734500000 USD
CY2019Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
335600000 USD
CY2018Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
218200000 USD
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
772100000 USD
CY2019Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
821100000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1765400000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1442800000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
712700000 USD
CY2018Q4 regn Capitalandfacilityleaseobligationsnoncurrent
Capitalandfacilityleaseobligationsnoncurrent
708500000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
273000000.0 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
361700000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
3434900000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
2977200000 USD
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4388400000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3911600000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6587800000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5254300000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16500000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12300000 USD
CY2019Q3 us-gaap Treasury Stock Value
TreasuryStockValue
488400000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
396400000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
10504400000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13939300000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11734500000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2048400000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1663500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5693900000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4783000000.0 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
663400000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
557000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2353500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1584800000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
419900000 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
369200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1248000000.0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1064900000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
1309900000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
1036600000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4159800000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2966700000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
738500000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
626900000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1534100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1816300000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37800000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16400000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28700000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81800000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
7800000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
7400000 USD
us-gaap Interest Expense
InterestExpense
23500000 USD
us-gaap Interest Expense
InterestExpense
20800000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30000000.0 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9000000.0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5200000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
61000000.0 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
768500000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
635900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1539300000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1877300000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98900000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
215500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
253300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594700000 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
us-gaap Net Income Loss
NetIncomeLoss
1624000000.0 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.86
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.14
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109400000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107800000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114200000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114800000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594700000 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
us-gaap Net Income Loss
NetIncomeLoss
1624000000.0 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000000.0 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
700000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
31500000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6900000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-300000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
300000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2700000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2400000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
670300000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
595700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1352600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1619500000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
8757300000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
140900000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10700000 USD
CY2019Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10500000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
54000000.0 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
114800000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
461100000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15100000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
9444700000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13900000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
29700000 USD
CY2019Q2 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
11700000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109200000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
193100000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000.0 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
9755900000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8300000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2019Q3 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
6000000.0 USD
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
48700000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
112700000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
700000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
10504400000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
6144100000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13600000 USD
CY2018Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
-700000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85800000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
477900000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9700000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6567500000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19800000 USD
CY2018Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
31900000 USD
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
37600000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
551400000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4100000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7186400000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
57300000 USD
CY2018Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45200000 USD
CY2018Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
42600000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
116500000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594700000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1100000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
7868200000 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
us-gaap Net Income Loss
NetIncomeLoss
1624000000.0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
156000000.0 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
105400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
330800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
300700000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-113200000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
82700000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
110000000.0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
33500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
460900000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
228600000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
227200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
281600000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21200000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
87800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
375800000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29500000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119900000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
179900000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
318800000 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-157700000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1642600000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1466300000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2834900000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1533600000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1306400000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
644100000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
290600000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
297600000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1819100000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1197100000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163500000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
87400000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
40500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
77100000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29400000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5900000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-82900000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
275100000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1480200000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
825200000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1397300000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1100300000 USD
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
91400000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
524300000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
479000000.0 USD
CY2019Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
136700000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
85300000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
344300000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
332500000 USD
CY2018Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
97100000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
669600000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
594700000 USD
us-gaap Net Income Loss
NetIncomeLoss
1323800000 USD
us-gaap Net Income Loss
NetIncomeLoss
1624000000.0 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109400000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107800000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4800000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7100000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000.0 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114200000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114800000 shares
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.06
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.86
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
14.14
CY2019Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4148900000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
27800000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
700000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4176000000.0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3026600000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000000.0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18400000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1493100000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1342200000 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2682900000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1667000000.0 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4176000000.0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3009200000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
313300000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
400000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
235800000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
300000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
549100000 USD
CY2019Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1482600000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6100000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
900700000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
2383300000 USD
CY2018Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
18400000 USD
CY2019Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2019Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
15700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-58400000 USD
CY2018Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4900000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
21000000.0 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
43100000 USD
CY2018Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
45500000 USD
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
229000000.0 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
226800000 USD
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
633500000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
571100000 USD
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
49400000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
24400000 USD
CY2019Q3 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
432400000 USD
CY2018Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
328900000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1151200000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
1344300000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
663700000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
712700000 USD
CY2018Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
723900000 USD
CY2018Q4 us-gaap Capital Leases Net Investment In Direct Financing Leases Accumulated Amortization
CapitalLeasesNetInvestmentInDirectFinancingLeasesAccumulatedAmortization
61700000 USD
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3600000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
10800000 USD
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6900000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21400000 USD
CY2019Q3 regn Finance Lease Cost
FinanceLeaseCost
10500000 USD
regn Finance Lease Cost
FinanceLeaseCost
32200000 USD
regn Finance Lease Remaining Lease Term
FinanceLeaseRemainingLeaseTerm
P2Y5M1D
CY2019Q3 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.0289
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1900000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
5700000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8000000.0 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
21200000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6600000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
20100000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3300000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
725000000.0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2000000.0 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q3 regn Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2300000 USD
CY2019Q3 regn Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
0 USD
CY2019Q3 regn Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
4300000 USD
CY2019Q3 regn Finance Lease Liability Payments Due After Year Six
FinanceLeaseLiabilityPaymentsDueAfterYearSix
0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28400000 USD
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
772000000.0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3100000 USD
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
53200000 USD
CY2019Q3 regn Lessee Operating Lease Liability Debt Financing Costs
LesseeOperatingLeaseLiabilityDebtFinancingCosts
0 USD
CY2019Q3 regn Lessee Finance Lease Liability Debt Financing Costs
LesseeFinanceLeaseLiabilityDebtFinancingCosts
6100000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25300000 USD
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
712700000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
10400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
26400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3800000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
28400000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
27900000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2200000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
7000000.0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1500000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4100000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
0 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
25400000 USD
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
89700000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.129
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.065
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.140
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.135
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1384800000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1087800000 USD
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2018Q3 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1397300000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1100300000 USD
CY2019Q3 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
100500000 USD
CY2018Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
54500000 USD
CY2018Q3 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
40500000 USD
CY2017Q4 regn Accrued Capital Expenditures
AccruedCapitalExpenditures
41800000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
Recently Issued Accounting Standards <div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments </span><span style="font-family:inherit;font-size:10pt;">("ASU 2016-13"). ASU 2016-13 requires an entity to measure and recognize expected credit losses for certain financial instruments, including trade receivables, as an allowance that reflects the entity's current estimate of credit losses expected to be incurred. For available-for-sale debt securities with unrealized losses, the standard requires allowances to be recorded through net income instead of directly reducing the amortized cost of the investment under the current other-than-temporary impairment model. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. We do not expect the adoption of this standard to have a significant impact on our financial statements or internal controls; however, the ultimate impact will depend on the composition of the Company's portfolio of financial instruments as of the adoption date.</span></div>

Files In Submission

Name View Source Status
0001532176-19-000034-index-headers.html Edgar Link pending
0001532176-19-000034-index.html Edgar Link pending
0001532176-19-000034.txt Edgar Link pending
0001532176-19-000034-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
regn-093019x10q.htm Edgar Link pending
regn-093019x10q_htm.xml Edgar Link completed
regn-20190930.xsd Edgar Link pending
regn-20190930_cal.xml Edgar Link unprocessable
regn-20190930_def.xml Edgar Link unprocessable
regn-20190930_lab.xml Edgar Link unprocessable
regn-20190930_pre.xml Edgar Link unprocessable
regn-ex311x09302019x10q.htm Edgar Link pending
regn-ex312x09302019x10q.htm Edgar Link pending
regn-ex32x09302019x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending